Dsm Firmenich AG is a specialty ingredients company operating in the nutrition, health, and beauty sectors. The group consists of three main business units: Perfumery & Beauty, which develops fragrances and beauty ingredients; Taste, Texture & Health, which provides flavors, sweeteners, and functional ingredients for food and beverages; and Health, Nutrition & Care, which offers vitamins, minerals, and customized solutions for human and animal health. The company serves global customers in the food, beverage, personal care, and pharmaceutical industries. Dsm Firmenich was formed in 2023 through the merger of DSM and Firmenich. Notable products include Hedione, Ambrox, and Furaneol, while the group also produces omega-3 from algae and low-carbon sweeteners.

Summarised from the company's own disclosures, fiscal year ended Dec 2024

Industry Specialty Chemicals Homepage investors.dsm-firmenich.com
Sector Basic Materials IR page investors.dsm-firmenich.com/en/investors.html
Tags
fragrances, flavors, vitamins, nutritional ingredients, beauty ingredients, sweeteners, omega-3, animal nutrition, human health, specialty chemicals, Hedione, Ambrox, Furaneol, Gist-Brocades, Roche Vitamins, DRT, Firmenich (International) SA
Press page —

Metrics

Valuation  
Market cap € 26.425B
Market cap (USD) $ 29.205B
P/E 77.27
PEG —
P/BV 1.43
P/S 2.93
P/OCF 18.29
P/FCF 32.34
Dividend yield —
Turnover / mcap —
Returns  
ROE -5.1%
ROI -5.6%
ROIC 3.1%
Profit margin -11.5%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -10.4%
Quality  
Profitable No
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -41.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006
Revenue 9.034B 12.799B 10.627B 8.39B 9.204B 8.106B 9.01B 9.267B 8.632B 7.92B 8.935B 9.283B 9.618B 9.131B 9.193B 9.05B 7.866B 9.297B 8.757B 8.38B
Net profit -1.039B 280M 2.153B 1.715B 1.68B 508M 758M 1.077B 1.769B 621M 88M 145M 271M 288M 814M 507M 337M 577M 429M 547M
Free cash flow 817M 1.133B — — — — — — — — — — — — — — — — — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006
Share price 63.97 107.8 102.6 — — — — — — — — — — — — — — — — —
Price performance 12m -0.41 0.05 — — — — — — — — — — — — — — — — — —

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (EUR) 1.39B 1.6B 1.51B 2.55B 2.59B 1.84B
↳ YoY growth +15.2% -5.9% +69.3% +1.4% -28.9%
↳ 5y CAGR +5.8%
Other receivables (EUR) 60M 32M 78M 183M 129M 105M
Borrowings, current (EUR) 102M 104M 86M 716M 836M —
Borrowings, non-current (EUR) 3.48B 2.99B 2.98B 4.11B 4.44B —
Cash and deposits (EUR) 871M 1.56B 2.76B 2.46B 2.67B 1.78B
Net debt (borrowings + leases - cash) (EUR) 2.72B 1.53B 309M 2.37B 2.61B —
Cash flow detail
Operating cash flow (EUR) — — — 1.27B 1.78B 1.45B
Purchases of property, plant and equipment (EUR) — — — -555M -645M -628M
Purchases of intangible assets (EUR) — — — -129M -119M -136M
Change in receivables (cash effect) (EUR) — — — 49M -18M -16M
Change in inventories (cash effect) (EUR) — — — 89M -38M -89M
Change in payables (cash effect) (EUR) — — — 126M 97M 5M
Dividends paid (cash effect) (EUR) -429M -424M -459M -582M -667M -718M
Share buybacks (cash effect) (EUR) -309M -165M -210M -256M -706M -1.18B
Interest paid (cash effect) (EUR) — — — -61M -67M -64M
Income taxes paid (cash effect) (EUR) — — — -179M -275M -320M
Share-based compensation (EUR) — — — 23M 31M 38M
Operating cash flow before change in receivables (EUR) — — — 1.22B 1.8B 1.46B
Free cash flow (OCF - PPE - intangibles) (EUR) — — — 581M 1.01B 681M
Income detail
Research and development expense (EUR) 398M 323M 295M 652M 888M 713M
↳ 5y CAGR +12.4%
Total comprehensive income (EUR) 185M 2.32B 1.94B 2.18B 453M -1.59B
Comprehensive income to owners (EUR) 187M 2.31B 1.93B 2.18B 418M -1.62B
Reported Mar 2, 2022 Mar 2, 2022 Mar 2, 2023 Mar 11, 2025 Mar 11, 2025 Feb 21, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

dsm-firmenich reports Q3 2026 trading update Bull 4 Bear 0 Guidance

Financial & Regulatory News Press releases 2026

share

print

Download

share

Share

Ad hoc announcement pursuant to article 53 LR

Kaiseraugst (Switzerland), Maastricht (Netherlands), November 4, 2026

Good top-line growth with sequential margin expansion

Highlights

  • Good like-for-like (LFL) sales growth of 5% in the quarter, consistent with year-to-date performance
  • Further sequential step-up in Adjusted EBITDA margin to 20.4% in the quarter
  • 2026-2028 action plan aimed at accelerating financial performance, fully on track
  • FY 2026 Outlook: LFL sales growth increased to around 5% (previously 2-4%)

Dimitri de Vreeze, CEO, commented: “We delivered another good quarter of volume-led growth and continued Adjusted EBITDA margin improvement. All businesses contributed well, demonstrating the quality of our portfolio in an ongoing highly dynamic global macroeconomic environment. Moving into the fourth quarter, business conditions remain supportive, with a healthy innovation pipeline, high win rates, and continued good sales growth.

We are well on track to deliver our 2026 targets, driving top-line growth and margin expansion, while maintaining a strong focus on cash and capital discipline. In addition, our cost savings and restructuring program are progressing well. Together, this provides us with an excellent platform to deliver on our 2027-2028 targets.”

Group Performance – Continuing Operations

In the third quarter of 2026, dsm-firmenich delivered good, volume-led LFL sales growth of 5%, consistent with year-to-date performance, reflecting continued good business momentum across the portfolio. This positive momentum was driven by high win rates on customer briefs and strong performance across regional and local accounts. 

Adjusted EBITDA in the quarter was up 8% on a LFL basis and the Adjusted EBITDA margin increased sequentially to 20.4%, which includes an 80 bps negative foreign exchange effect versus Q3 last year. The company continues to address cost inflation through a range of initiatives, including its cost savings and restructuring program and further pricing actions.

in € millions Q3 YTD 2026 Q3 YTD 2025 % LFL Q3 2026 Q3 2025 % LFL
Sales 7,032 6,881 5 2,368 2,238 5
Adj. EBITDA 1,382 1,364 7 482 458 8
Adj. EBITDA margin (%) 19.7 19.8 20.4 20.5

FY 2026 Outlook

The company continues to deliver on its 2026 Strategic Action Plan and expects Continuing Operations in FY 2026 to deliver:

  • Like-for-Like (LFL) sales growth: around 5% (previously 2-4%)
  • Adjusted EBITDA margin: around 20%
  • Cash conversion: Adjusted Gross Operating Free Cash Flow to Sales of 11-12%

Strategic ambitions

dsm-firmenich operates through three unique and complementary Business Units: Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care. These businesses are supported by clear strategic choices, a simplified operating model, and a strong focus on customer-driven innovation.

The strategic ambition is to grow by leveraging a unique combination of science, creativity, and customer intimacy, while anchoring performance through operational excellence, disciplined capital allocation, cost saving programs, and consistent commercial practices across the Group. With the Group-wide transformation successfully executed, following the announced divestment of Animal Nutrition & Health, the focus has shifted to accelerating growth and performance across the three Business Units.

Looking ahead, the priority is to continue executing the plan for the remainder of 2026 and throughout 2027, driving growth and synergies, expanding EBITDA margins, and improving cash conversion. This will be underpinned by normalized capital expenditure, tighter working capital management, and greater cost discipline.

The materials from the March 2026 Capital Markets Day are available here .

Share buyback program

On September 30, the company successfully completed its share repurchase program, repurchasing a total number of 7,169,147 shares at an average price of €75.32, for a total consideration of €540 million. Of the total, 680,701 shares were repurchased to cover commitments under the Group’s share-based compensation plans, and 6,488,446 shares were repurchased for capital reduction purposes. The latter are expected to be cancelled by the end of Q1 2027, reducing the number of issued shares by approximately 2.6%, from 253,626,947 to 247,138,501.

Financial calendar

February 18, 2027 – Publication of dsm-firmenich FY 2026 results
March 24, 2027 – AGM, Kaiseraugst (CH)
May 4, 2027 – Publication of dsm-firmenich Q1 2027 trading update
July 29, 2027 – Publication of dsm-firmenich H1 2027 results
November 3, 2027 - Publication of dsm-firmenich Q3 2027 trading update

Additional information

Today dsm-firmenich will hold a webcast for investors and analysts at 9:00 am CET. Details on how to access this call can be found on www.dsm-firmenich.com

Notes to this trading update

The reported financial data in this trading update have not been audited.

A PDF version of this press release can be found here .

Our stories 2026

share

print

share

Share

Written by Inge Massen-Biemans, Chief Sustainability Officer, dsm-firmenich

**Chocolate

       Omega-3        Mint **

What if your favorite chocolate bar suddenly cost twice as much? What if your morning supplement was not available on the shelf due to supply problems? Or what if changes in growing conditions affected a key ingredient, meaning the scent of a beauty product you know and love was no longer quite the same?

These aren't distant possibilities. Climate change is affecting harvests. Natural resources are under pressure. Geopolitical uncertainty is making supply chains less predictable. And pressures on livelihoods are impacting the people and communities behind the products we use every day. Together, these forces are already reshaping how products are sourced, manufactured, and brought to market.

This is where sustainability and business strategy must come together.

Because when you strip away the jargon, sustainability comes down to a straightforward idea: creating value in a way that allows people, the planet and business to thrive, today and in the future.

Therefore, sustainability is about anticipating change, identifying risks and opportunities early, and finding new ways to create value in a more complex world. And often, the most impactful innovations begin with a constraint: a scarce resource, a vulnerable supply chain, impacted livelihoods, or a changing market.

At dsm-firmenich, this mindset is a core part of how we operate. It shapes how our teams, early on, think about future challenges. From rethinking how products are made and where ingredients come from, to using resources more efficiently. This helps us to future-proof our business, to address the sustainability challenges and opportunities of our customers and to create impact at scale, together.

Here are three examples of how our businesses are turning sustainability challenges and evolving market needs into opportunities.


What if the answer to a cocoa shortage was... less cocoa?​

Can you imagine a world without chocolate? Neither can I. But few ingredients illustrate today's challenges more clearly than cocoa.

In 2024, poor harvests and disease affected major cocoa-growing regions, pushing prices to record highs, and highlighting the fragility of a supply chain that many manufacturers depend on.

At dsm-firmenich, we anticipated that climate-related pressures could lead to periods of cocoa scarcity and significant market disruption. 

Rather than waiting for the industry to react, we took a proactive approach by bringing together experts from our Science & Research teams and Taste, Texture & Health business unit to deepen our understanding of cocoa
and develop future-ready solutions.

image1

Our ambition was clear: to help our customers continue to deliver the delicious chocolate experiences consumers love while reducing reliance on cocoa. This would mean improving resilience to supply disruptions and price volatility and supporting a lower environmental footprint too. Our answer? That’s: CocoaCraze™.​

“Cocoa is never just one flavor. It's dark, nutty, malty, creamy, woody, chocolatey, caramelly, sometimes even vanilla-like. As a flavorist, decoding cocoa and recreating its full sensory richness is already fascinating and remains an exciting challenge.​

Today’s most inspiring challenge goes even further: creating delicious cocoa alternatives. It requires the very best of our expertise, combining deep research, a thorough understanding of cocoa's sensory signature, and the creative power of our flavor palette. By carefully selecting and recombining ingredients, we can craft solutions that deliver the delight, authenticity, and indulgence consumers expect while using resources more responsibly. Our CocoaCraze™ concept achieves this and is built to create tailor made solutions.

When upcycled ingredients become part of the solution, the challenge becomes even more rewarding. Turning what could have been side-streams into taste, quality, and pleasure is exactly the kind of innovation that inspires me every day.”​

- Brigitte Pellen, Principal Flavorist, Vanilla & Brown Notes

CocoaCraze™ is a family of customized cocoa reduction solutions. By tailoring flavor profiles to match the unique characteristics of cocoa in each application, our flavorists can enable cocoa reductions of up to 50%.

×

Using less cocoa creates benefits beyond cost too. It helps lower the environmental footprint of products by reducing the land use, water consumption, and greenhouse gas emissions associated with cocoa production. At the same time, it strengthens business resilience by giving manufacturers additional options to navigate cocoa supply shortages, price volatility, and long-term climate-related risks.

Because let’s face it: we don’t want to live in a world without chocolate. As climate change increasingly threatens cocoa production, our scientists and flavorists found a way to save resources and use less cocoa, while protecting what so many of us like most: a lovely chocolate experience. 


Omega-3’s fishy little secret​

Every few years, something terrible happens in the oceans: El Niño strikes. It’s a recurring climate pattern that causes ocean waters to become unusually warm, of which the results are disastrous for marine life and fish. For the remainder of 2026 and into 2027, weather forecasts are predicting a ‘historic impact’ on the oceans and fish populations.1​

Among the many consequences, El Niño puts huge pressure on the production of an important nutrient we all need: omega-3.

story-3

Why is omega-3 important for us?​​

Did someone ever tell you omega-3 is good for you? Well, they were right. Omega-3 fatty acids are essential nutrients that support heart, brain, and eye health throughout life. There is one issue with omega-3 though: our body doesn’t produce it. In fact, 76% of the global population does not meet recommended intakes of EPA and DHA, the two important fatty acids in omega-32. So we need to supplement our food with these fatty acids. 

Traditionally, omega-3 is sourced from fish. But here’s a surprising fact: fish get their omega-3 from what they eat, and that all starts with the microalgae they eat.

So, if fish get their omega-3 from algae, why don’t we go straight to the source too?

It’s an idea that’s been decades in the making. In the 1980s, NASA researchers were already exploring what algae could offer future space missions, from producing oxygen to providing nutrition3. They weren’t necessarily looking for a new source of omega-3, but their work helped demonstrate the potential of algae as a way of producing valuable nutrients.

Fast forward several decades, and that potential has become a reality. Scientists can now cultivate specific algae strains in controlled fermentation systems: these microorganisms are grown in tanks, where conditions like temperature, nutrients, and oxygen can be carefully managed to help them produce the oils we need.

×

The result is a different way of producing EPA and DHA: grow the algae directly, then extract the omega-3 oils they naturally produce. That means we don't need to rely on fish to be the middle-men.

story3

That’s the thinking behind life’s®OMEGA , the first and only commercially available microalgal omega-3 for dietary supplements from our Health, Nutrition & Care business unit.

Going directly to the source helps us diversify how we produce an important nutrient, while reducing reliance on marine resources and the pressure that comes with sourcing from the ocean.

Sometimes the biggest opportunities come from cutting the middle-man, or in this case, ‘the middle-fish’.


  1. Synopsis: ENSO-neutral conditions may transition to La Niña co​

  2. Calder PC, Cawood AL, et al., Nutrition Research Reviews (2025)

  3. https://spinoff.nasa.gov/Spinoff2015/hm_4.html ​


Why it’s cool to protect the future of freshness​​​

Mint may seem like an ‘everyday’ ingredient. But from the toothpaste we use in the morning to the fragrances we wear and the food and beauty products we enjoy throughout the day, mint plays a surprisingly important role in consumer products. Yet behind this everyday feeling of freshness lies a growing challenge.

India is one of the world’s largest mint-growing regions and a critical source of the natural mint oil used in products around the world, from fragrances and beauty products to oral care. In fact, 85% of the world’s mint in oral care and confectionary products is produced in India and it’s an important ingredient used across our Perfumery & Beauty business unit.

But the future of that supply is under strain. Mint growers in the region are increasingly suffering from climate variability, water scarcity, disease pressure, and economic uncertainty.

For farmers, that can mean less predictable yields. For businesses that rely on mint, it can mean a less dependable supply of an ingredient they need.

So resilience has to start in the field.

Through the Mint with Purpose program, we work with Norex, our local partner, and farming communities to tackle some of these challenges. Farmers receive training in practices that can improve soil health, use water more efficiently, and increase yields, while the program also strengthens local distillation capabilities and creates opportunities for entrepreneurship, including for women and young adults.

“Within a year of joining Mint with Purpose, I harvested 51 kg of mint oil, earning a net profit of INR 48,800 per acre. Mint with Purpose also supported me in accessing Sukanya Samriddhi Yojana [a government savings scheme that helps parents save for their daughters’ future] — giving me peace of mind about my daughters’ future education.”​

— Puja, 30, farmer from Tomda, Uttar Pradesh, India​

“Thanks to Mint with Purpose, my oil yield increased by nearly 39%. I never imagined such earnings from mint. GALS [Gender Action Learning System] training changed my family dynamics — I now make financial decisions jointly with my husband. Selling surplus from my vegetable garden earned me an additional INR 10,500.”​​

—Sarwati, 42, farmer and GALS graduate from Nawabpura, Uttar Pradesh, India​​

story

We know how important mint is to consumers. It isn't just an ingredient; it's bringing the essence of freshness to our products. Through our programs, we aim to protect the future of that freshness. 


Bringing progress to life by rethinking what’s possible​

Cocoa reduction, algae-based omega-3, and sustainable mint farming practices in India may seem like very different stories. But they all start with the same question: how can we turn the challenges of a rapidly changing world into opportunities?

For me, that’s what sustainability delivering business value is really about. It’s not about predicting exactly what the future will look like, but about understanding where change is heading, anticipating what it could mean for people, the planet, our businesses and the markets we serve, and using those insights to find better ways forward. Sometimes, they are small steps, sometimes, big leaps.

The pressures facing our supply chains and communities, and the growing constraints on natural resources are not going away (if anything, they will become more complex), but neither is our ability to innovate and adapt.

That is where we at dsm-firmenich see the opportunity: sustainability can be a catalyst for better ideas, stronger businesses, and more resilient value chains. It gives us a reason to question what we make, how we make it, and where it comes from, and in doing so, find new ways to create value for people, the planet and our customers.

Learn more about sustainability at dsm-firmenich, here .​

Logo

©2026 dsm-firmenich. All rights reserved.

Cookie Preferences

Banner close

Cookies are important to the proper functioning of a site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to optimize site functionality, and deliver content tailored to your interests. You may choose to consent to our use of these technologies, or manage your own preferences.

Privacy Accept All Decline All More Information

Powered by

Company news Press releases 2026

share

print

Download

share

Share

Ad hoc announcement pursuant to article 53 LR

Kaiseraugst (Switzerland), Maastricht (Netherlands), October 19, 2026

dsm-firmenich, innovators in nutrition, health, and beauty, today confirms that shareholders at the Extraordinary General Meeting (EGM) held on October 19, 2026, elected Richard Ridinger as Chairman of the Board of Directors, as previously announced on August 18 .

Richard Ridinger succeeds Thomas Leysen, who has retired from the Board. Thomas played a pivotal role in shaping the company’s strategic direction and establishing a strong foundation for its next phase of growth and value creation.

Richard Ridinger has served as an independent member of the Board of Directors of dsm-firmenich since 2023 and, in addition to his role as Chairman, has also been elected as a member of the Compensation Committee. He brings extensive executive and board-level experience across Pharma, Home & Personal Care, and Nutrition & Health, as well as a deep understanding of the company, its strategy and stakeholders.

The Board looks forward to working with Richard Ridinger as dsm-firmenich continues to execute its strategy, and create sustainable long-term value for shareholders and other stakeholders. The Board also expresses its sincere gratitude to Thomas for his outstanding leadership and dedication during his tenure.

The detailed voting results of the Extraordinary General Meeting are available on the company’s website .

You can download this press release here .

Biography Richard Ridinger

A full biography of Richard Ridinger is available here and a portrait picture can be downloaded here . 

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for people and the planet. dsm-firmenich is a Swiss company, listed on Euronext Amsterdam and SIX Swiss Exchange, with operations in almost 60 countries and revenues of more than €9 billion for its Continuing Operations following the divestment of Animal Nutrition & Health. With a diverse, worldwide team of nearly 21,000 employees, we bring progress to life every day, everywhere, for billions of people. www.dsm-firmenich.com

Prompts

Dsm Firmenich AG (ticker DSFIR), listed in Netherlands.

ETFs Holding Dsm Firmenich AG

ETF Weight in ETF Shares Market value As of
BINV 1.91% 98,530 $ 9.344M Jun 30, 2026
FEOE 0.50% 85,195 $ 9.474M Aug 31, 2026
SROI 0.41% 708 $ 76.238K Jul 31, 2026
AVIV 0.17% 31,454 $ 3.585M Nov 16, 2026
AVDE 0.16% 273,143 $ 31.134M Nov 16, 2026
DFIV 0.13% 253,091 $ 29.451M Nov 12, 2026
TIER 0.13% 414 $ 44.632K Jul 31, 2026
DFSI 0.12% 12,167 $ 1.416M Nov 12, 2026
NTSI 0.07% 3,408 $ 323.398K Jun 30, 2026
DFAI 0.06% 96,200 $ 11.194M Nov 12, 2026
DXIV 0.05% 1,076 $ 125.208K Nov 12, 2026
DFIC 0.05% 63,442 $ 7.382M Nov 12, 2026
AVSD 0.04% 1,439 $ 164.025K Nov 16, 2026
DFAX 0.02% 23,761 $ 2.765M Nov 12, 2026
FENI 0.02% 19,568 $ 1.856M Jun 30, 2026